ARLEVON Trademark

Trademark Overview

On Tuesday, January 11, 2011, a trademark application was filed for ARLEVON with the United States Patent and Trademark Office. The USPTO has given the ARLEVON trademark a serial number of 85214755. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 25, 2014. This trademark is owned by Glaxo Group Limited. The ARLEVON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
arlevon

General Information

Serial Number85214755
Word MarkARLEVON
Filing DateTuesday, January 11, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 25, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe word(s) "ARLEVON" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 14, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, August 25, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 25, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 16, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 15, 2014EXTENSION 5 GRANTED
Thursday, January 9, 2014EXTENSION 5 FILED
Thursday, January 9, 2014TEAS EXTENSION RECEIVED
Wednesday, August 7, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 6, 2013EXTENSION 4 GRANTED
Friday, July 5, 2013EXTENSION 4 FILED
Friday, August 2, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 5, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 15, 2013EXTENSION 3 GRANTED
Friday, December 14, 2012EXTENSION 3 FILED
Friday, December 14, 2012TEAS EXTENSION RECEIVED
Tuesday, July 31, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 30, 2012EXTENSION 2 GRANTED
Tuesday, July 17, 2012EXTENSION 2 FILED
Friday, July 27, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 17, 2012TEAS EXTENSION RECEIVED
Wednesday, January 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 9, 2012EXTENSION 1 GRANTED
Monday, January 9, 2012EXTENSION 1 FILED
Monday, January 9, 2012TEAS EXTENSION RECEIVED
Tuesday, July 19, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 24, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2011PUBLISHED FOR OPPOSITION
Saturday, April 16, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 15, 2011ASSIGNED TO LIE
Thursday, March 31, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 30, 2011ASSIGNED TO EXAMINER
Friday, January 14, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 14, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

arlevon pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological